tirzepatide irritability Weight Loss Adverse events associated with tirzepatide:

Together, lets empower your wellness journey!

It is not ideal to compare your own progress to someone elses, but it is more beneficial to look at your own progress while using tirzepatide approved for weight loss over time and keep realistic expectations

Combined with work stress, family life, and sleep challenges, recovery can be difficult

[1] GLP-1s remain covered for: BMI 40 (Class III/morbid obesity) Type 2 Diabetes (Mounjaro, not Zepbound) Major Adverse Cardiac Events history Employers who opt-in to add weight loss drug coverage California Medi-Cal Alert: GLP-1 Exclusion Effective January 1, 2026 If you have Kaiser through Medi-Cal, weight loss GLP-1 coverage is ending

Semaglutide | Feature | Tirzepatide | Semaglutide | Mechanism | Dual GIP/GLP-1 agonist | GLP-1 agonist only | | Average weight loss | 20-25% | 15-17% | | Dosing frequency | Weekly | Weekly | | Side effects | Generally comparable | GI side effects common | | Cost (brand) | $1,000-1,200/month | $1,000-1,400/month | More detail on the science behind GIP and GLP-1 Explanation of how these hormones naturally work in the body Why dual-action is more effective Comparison with older weight loss medications SURMOUNT Clinical Trial Program SURMOUNT-1 Trial (published in NEJM 2022): 2,539 participants without diabetes 72-week study Results by dose: * 5 mg: 15.0% weight loss * 10 mg: 19.5% weight loss * 15 mg: 20.9% weight loss * Placebo: 3.1% weight loss 89% of participants on 15 mg dose lost at least 5% body weight 57% lost at least 20% body weight on highest dose SURMOUNT-2 Trial: Participants with type 2 diabetes Average weight loss 12-15% (diabetes makes weight loss harder) Significant improvements in HbA1c and cardiovascular risk factors SURMOUNT-3 Trial: Weight maintenance after initial loss Participants who continued tirzepatide maintained weight loss Those who switched to placebo regained significant weight Additional Benefits Observed: Reduced waist circumference Improved blood pressure Better cholesterol levels Decreased liver fat Improved quality of life scores Expand by adding: More details on study design and methodology Specific patient examples from trials Comparison with other weight loss interventions (surgery, other medications) Long-term follow-up data Who Is a Candidate for Tirzepatide

BBB disruption in healthy aging The BBB undergoes a number of deleterious changes during normal aging